Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Giuseppe Comella
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Chemicals & Drugs
Concepts & Ideas
Disorders
Sign-in to see full Profile
Network (preview)
61
Comella, Pasquale
36
Frasci, Giuseppe
23
Casaretti, Rossana
18
Avallone, Antonio
15
Daponte, Antonio
14
Gravina, Adriano
13
Caponigro, Francesco
12
De Rosa, Vincenzo
12
Panza, Nicola
11
De Cataldis, Giuseppe
11
De Lucia, Luigi
11
Maiorino, Luigi
10
Lorusso, Vito
10
D'Aiuto, Giuseppe
10
Botti, Gerardo
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Giuseppe Comella (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2007: Casula Milena; Colombino Maria; Satta Maria P; Cossu Antonio; Lissia Amelia; Budroni Mario; Simeone Ester; Calemma Rosa; Loddo Cinzia; Caracò Corrado; Mozzillo Nicola; Daponte Antonio; Comella Giuseppe; Canzanella Sergio; Guida Michele; Castello Giuseppe; Ascierto Paolo A; Palmieri Giuseppe;
Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy.
European journal of cancer (Oxford, England : 1990) 2007;43(1):137-43.
-
2006: Palmeri Sergio; Lorusso Vito; Palmeri Laura; Vaglica Marina; Porta Camillo; Nortilli Rolando; Ferraú Francesco; Comella Giuseppe; Massidda Bruno; Danova Marco;
Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multicenter, randomized, phase II study.
Cancer 2006;107(12):2898-905.
-
2006: Frasci G; D'Aiuto G; Comella P; Thomas R; Botti G; Di Bonito M; De Rosa V; Iodice G; Rubulotta M R; Comella G;
Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study.
British journal of cancer 2006;95(8):1005-12.
-
2006: Di Bartolomeo Maria; Buzzoni Roberto; Mariani Luigi; Ferrario Erminia; Katia Dotti; Gevorgyan Arpine; Zilembo Nicoletta; Bordonaro Roberto; Bochicchio Anna Maria; Massidda Bruno; Ardizzoia Antonio; Marini Giovanni; Aitini Enrico; Schieppati Giuseppe; Comella Giuseppe; Pinotti Graziella; Palazzo Salvatore; Cicero Giovanni; Bajetta Emilio; Villa Eugenio; Fagnani Daniele; Reguzzoni Giorgio; Agostana Biagio; Oliani Cristina; Kildani Basem; Duro Maria; Botta Mario; Mozzana Ruggiero; Mantovani Giovanni
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
Oncology 2006;71(5-6):341-6.
-
2006: Palmieri Giuseppe; Satriano Sabrina M R; Budroni Mario; Cossu Antonio; Tanda Francesco; Canzanella Sergio; Caracò Corrado; Simeone Ester; Daponte Antonio; Mozzillo Nicola; Comella Giuseppe; Castello Giuseppe; Ascierto Paolo A
Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma.
BMC cancer 2006;6():266.
-
2005: Frasci G; D'Aiuto G; Comella P; Thomas R; Botti G; Di Bonito M; D'Aiuto M; Romano G; Rubulotta M R; Comella G
A 2-month cisplatin-epirubicin-paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(8):1268-75.
-
2005: Gasparini Giampietro; Meo Sabrina; Comella Giuseppe; Stani Simonetta Chiara; Mariani Luigi; Gamucci Teresa; Avallone Antonio; Lo Vullo Salvatore; Mansueto Giovanni; Bonginelli Paola; Gattuso Domenico; Gion Massimo
The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlates.
Cancer journal (Sudbury, Mass.) 2005;11(3):209-16.
-
2005: Daponte Antonio; Ascierto Paolo Antonio; Gravina Adriano; Melucci Mariateresa; Scala Stefania; Ottaiano Alessandro; Simeone Ester; Palmieris Giuseppe; Comella Giuseppe
Temozolomide and cisplatin in avdanced malignant melanoma.
Anticancer research 2005;25(2B):1441-7.
-
2005: Palmeri S; Vaglica M; Spada S; Filippelli G; Farris A; Palmeri L; Massidda B; Misino A; Ferraù F; Comella G; Leonardi V; Condemi G; Mangiameli A; De Cataldis G; Macaluso M C; Cajozzo M; Iannitto E; Danova M
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study.
Oncology 2005;68(4-6):438-45.
-
2005: Frasci Giuseppe; D'Aiuto Giuseppe; Thomas Renato; Comella Pasquale; Di Bonito Maurizio; Lapenta Liliana; D'Aiuto Massimiliano; Botti Gerardo; Vallone Paolo; De Rosa Vincenzo; D'Aniello Roberta; Giordano Renato; Comella Giuseppe
Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patients.
Oncology 2005;68(4-6):391-7.
-
2005: Frasci Giuseppe; Comella Pasquale; Carreca Ignazio; DeCataldis Giuseppe; Muci Domenico; Brunetti Cosimo; Russo Anna; Palmeri Sergio; D'Aniello Roberta; Giordano Renato; D'Aiuto Massimiliano; Comella Giuseppe;
Weekly dose-dense cisplatin-epirubicin-paclitaxel administration with granulocyte colony-stimulating factor support does not substantially improve prognosis in extensive disease small-cell lung cancer. A SICOG phase II study.
Oncology 2005;68(2-3):223-9.
-
2004: Cantore M; Fiorentini G; Luppi G; Rosati G; Caudana R; Piazza E; Comella G; Ceravolo C; Miserocchi L; Mambrini A; Del Freo A; Zamagni D; Rabbi C; Marangolo M
Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in Oncology.
Journal of chemotherapy (Florence, Italy) 2004;16(6):589-94.
-
2004: Caponigro Francesco; Ionna Franco; Comella Giuseppe
New cytotoxic and molecular-targeted therapies of head and neck tumors.
Current opinion in oncology 2004;16(3):225-30.
-
2004: Frasci Giuseppe; Comella Pasquale; Thomas Renato; Di Bonito Maurizio; Lapenta Liliana; Capasso Immacolata; Botti Gerardo; Vallone Paolo; De Rosa Vincenzo; D'Aiuto Giuseppe; Comella Giuseppe
Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study.
Cancer chemotherapy and pharmacology 2004;53(1):25-32.
-
2003: Cantore M; Fiorentini G; Luppi G; Rosati G; Caudana R; Piazza E; Comella G; Ceravolo C; Miserocchi L; Mambrini A; Del Freo A; Zamagni D; Aitini E; Marangolo M
Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer.
Journal of experimental & clinical cancer research : CR 2003;22(4 Suppl):51-7.
-
2003: Colombino M; Cossu A; Arba A; Manca A; Curci A; Avallone A; Comella G; Botti G; Scintu F; Amoruso M; D'Abbicco D; d'Agnessa M R; Spanu A; Tanda F; Palmieri G
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting for MLH1 and MSH2 inactivation in familial cases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(10):1530-6.
-
2003: Delrio P; Lastoria S; Avallone A; Ravo V; Guida C; Cremona F; Izzo F; Palaia R; Ruffolo F; Puppio B; Guidetti G M; Cascini G L; Casaretti R; Tatangelo F; Marone P; Rossi G B; Budillon A; Petrillo A; De Rosa V; Comella G; Morrica B; Tempesta A; Botti G; Parisi V
[Early evaluation using PET-FDG of the efficiency of neoadjuvant radiochemotherapy treatment in locally advanced neoplasia of the lower rectum]
Tumori 2003;89(4 Suppl):50-3.
-
2003: Pivot X; Awada A; Gedouin D; Kerger J; Rolland F; Cupissol D; Caponigro F; Comella G; Lopez-Pousa J J; Guardiola E; Giroux B; Gérard B; Schneider M
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):373-7.
-
2003: Frasci Giuseppe; Comella Pasquale; De Cataldis Giuseppe; Maiorino Luigi; Fiore Francesco; De Rosa Vincenzo; Lapenta Liliana; Licenziato Marina; Comella Giuseppe;
Taxol plus gemcitabine and vinorelbine given every other week in advanced chemo-naïve non-small cell lung cancer patients.
Oncology 2003;65(4):378-9.
-
2002: Comella P; Casaretti R; De Rosa V; Avallone A; Izzo F; Fiore F; Lapenta L; Comella G
Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(12):1874-81.
-
2002: Colombino M; Cossu A; Manca A; Dedola M F; Giordano M; Scintu F; Curci A; Avallone A; Comella G; Amoruso M; Margari A; Bonomo G M; Castriota M; Tanda F; Palmieri G
Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1447-53.
-
2002: Comella P; Casaretti R; Crucitta E; De Vita F; Palmeri S; Avallone A; Orditura M; De Lucia L; Del Prete S; Catalano G; Lorusso V; Comella G
Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients.
British journal of cancer 2002;86(12):1871-5.
-
2002: Borner M M; Schoffski P; de Wit R; Caponigro F; Comella G; Sulkes A; Greim G; Peters G J; van der Born K; Wanders J; de Boer R F; Martin C; Fumoleau P
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2002;38(3):349-58.
-
2002: Caponigro Francesco; Rosati Gerardo; De Rosa Patrizia; Avallone Antonio; De Rosa Vincenzo; De Lucia Luigi; Comella Pasquale; Comella Giuseppe
Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
Oncology 2002;63(3):232-8.
-
2002: Frasci Giuseppe; D'Aiuto Giuseppe; Comella Pasquale; Thomas Renato; Capasso Immacolata; Botti Gerardo; Cortino Giuseppina Rosa; Di Bonito Maurizio; Rubulotta Rosaria; Vallone Paolo; Comella Giuseppe
A phase I-II study on a gemcitabine-cyclophosphamide-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients.
Oncology 2002;62(1):25-32.
-
2001: Comella G; Panza N
[New therapeutic strategies in microcytoma]
Minerva endocrinologica 2001;26(4):261.
-
2001: Frasci G; Lorusso V; Panza N; Comella P; Nicolella G; Bianco A; DeCataldis G; Belli M; Iannelli N; Massidda B; Mascia V; Comella G; De Lena M
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S65-9.
-
2001: Caponigro F; Avallone A; Budillon A; Comella P; Comella G
Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapy.
Anti-cancer drugs 2001;12(6):489-97.
-
2001: Frasci G; D'Aiuto G; Comella P; Thomas R; Capasso I; Botti G; Cortino G R; De Rosa V; Comella G;
Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: a Southern Italy Cooperative Oncology Group phase I/II study.
Seminars in oncology 2001;28(3 Suppl 10):50-6.
-
2001: Frasci G; Nicolella G; Comella P; Carreca I; DeCataldis G; Muci D; Brunetti C; Natale M; Piantedosi F; Russo A; Palmeri S; Comella G; Panza N
A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study.
British journal of cancer 2001;84(9):1166-71.
-
2001: Caponigro F; Massa E; Manzione L; Rosati G; Biglietto M; De Lucia L; Sguotti C; Sganga P; Avallone A; Comella P; Mantovani G; Comella G
Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(2):199-202.
-
2001: Cascinu S; Graziano F; Barni S; Labianca R; Comella G; Casaretti R; Frontini L; Catalano V; Baldelli A M; Catalano G
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
British journal of cancer 2001;84(4):470-4.
-
2001: Caponigro F; Avallone A; Rivellini F; Comella P; Ionna F; De Rosa V; Comella G
Phase I study of mitoxantrone, raltitrexed, levofolinic acid and 5-fluorouracil in advanced solid tumours.
Cancer chemotherapy and pharmacology 2001;47(2):113-6.
-
2001: Comella P; Biglietto M; Casaretti R; De Lucia L; Avallone A; Maiorino L; Di Lullo L; De Cataldis G; Rivellini F; Comella G
Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients. A phase I/II study of the Southern Italy Cooperative Oncology Group.
Oncology 2001;60(2):127-33.
-
2000: Daponte A; Ascierto P A; Gravina A; Melucci M T; Palmieri G; Comella P; Cellerino R; DeLena M; Marini G; Comella G;
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
Cancer 2000;89(12):2630-6.
-
2000: Comella P; De Vita F; Mancarella S; De Lucia L; Biglietto M; Casaretti R; Farris A; Ianniello G P; Lorusso V; Avallone A; Cartenì G; Leo S S; Catalano G; De Lena M; Comella G
Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(10):1323-33.
-
2000: Frasci G; D'Aiuto G; Comella P; Thomas R; Capasso I; Di Bonito M; Rivellini F; Carteni G; De Lucia L; Maiorino L; D'Aniello R; Frezza P; Lapenta L; Comella G
Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase II study.
Breast cancer research and treatment 2000;62(2):87-97.
-
2000: Frasci G; Lorusso V; Panza N; Comella P; Nicolella G; Bianco A; De Cataldis G; Iannelli A; Bilancia D; Belli M; Massidda B; Piantedosi F; Comella G; De Lena M
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(13):2529-36.
-
2000: Caponigro F; Comella P; Rivellini F; Avallone A; Budillon A; Di Gennaro E; Mozzillo N; Ionna F; De Rosa V; Manzione L; Comella G
Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(5):575-80.
-
2000: Comella P; De Vita F; De Lucia L; Casaretti R; Avallone A; Orditura M; Rivellini F; Palmeri S; Catalano G; Comella G
Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: a dose finding study in advanced previously treated colorectal carcinoma. Southern Italy Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(4):461-8.
-
2000: Comella P; Frasci G; Panza N; Manzione L; De Cataldis G; Cioffi R; Maiorino L; Micillo E; Lorusso V; Di Rienzo G; Filippelli G; Lamberti A; Natale M; Bilancia D; Nicolella G; Di Nota A; Comella G
Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(7):1451-7.
-
2000: Frasci G; Comella P; D'Aiuto G; Thomas R; Capasso I; Elmo M; Botti G; Cortino G R; Lapenta L; De Rosa V; Vallone P; Petrillo A; Comella G
Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(3):367-71.
-
2000: Caponigro F; Comella P; Budillon A; Bryce J; Avallone A; De Rosa V; Ionna F; Comella G
Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(3):339-42.
-
2000: Comella P; Panza N; Manzione L; De Cataldis G; Cioffi R; Maiorino L; Lorusso V; Lamberti A; Micillo E; Natale M; Bilancia D; Nicolella G; Di Nota A; Mancarella S; Frasci G; Comella G;
Interim analysis of a phase III trial comparing cisplatin, gemcitabine, and vinorelbine vs. either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non small-cell lung cancer. A Southern Italy Cooperative Oncology Group Study.
Clinical lung cancer 2000;1(3):202-7; discussion 208.
-
1999: Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):3948-55.
-
1999: Comella P; Lorusso V; Casaretti R; De Lucia L; Cartení G; Manzione L; Mancarella S; De Lena M; Comella G
Concurrent modulation of 5-fluorouracil with methotrexate and L-leucovorin: an effective and moderately toxic regimen for the treatment of advanced colorectal carcinoma. A multicenter phase II study of the Southern Italy Cooperative Oncology Group.
Tumori 1999;85(6):465-72.
-
1999: Frasci G; D'Aiuto G; Comella P; Apicella A; Thomas R; Capasso I; Di Bonito M; Cartenì G; Biglietto M; De Lucia L; Maiorino L; Piccolo S; Bianchi U; D'Aniello R; Lapenta L; Comella G
Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phase I study of the Southern Italy Cooperative Oncology Group.
Breast cancer research and treatment 1999;56(3):239-52.
-
1999: Frasci G; Panza N; Comella P; Nicolella G P; Natale M; Manzione L; Bilancia D; Cioffi R; Maiorino L; De Cataldis G; Belli M; Micillo E; Mascia V; Massidda B; Lorusso V; De Lena M; Carpagnano F; Contu A; Pusceddu G; Comella G
Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: a phase I-II study. Southern Italy Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2316-25.
-
1999: Comella P; Casaretti R; De Vita F; Avallone A; Orditura M; Petrillo A; Gravina A; Faranda A; Comis S; Comella G; Catalano G
Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: a phase I study of the Southern Italy Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(8):915-21.
-
1999: Comella P; Frasci G; Panza N; Manzione L; Lorusso V; Di Rienzo G; Cioffi R; De Cataldis G; Maiorino L; Bilancia D; Nicolella G; Natale M; Carpagnano F; Pacilio C; De Lena M; Bianco A; Comella G
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1526-34.
-
1999: Frasci G; Panza N; Comella P; Cartení G; Guida T; Nicolella G P; Natale M; Lombardi R; Apicella A; Pacilio C; Gravina A; Lapenta L; Comella G
Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: a dose-finding study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(3):355-8.
-
1999: Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
Cancer 1999;85(4):952-9.
-
1999: Cascinu S; Frontini L; Comella G; Barni S; Labianca R; Battelli N; Casaretti R; Zonato S; Pirovano M; Catalano G; Cellerino R
Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
British journal of cancer 1999;79(3-4):491-4.
-
1999: Frasci G; Panza N; Comella G; Pacilio G
Is there any impact of new drugs on the outcome of advanced NSCLC? An overview of the Southern Italy Cooperative Oncology Group trials.
The oncologist 1999;4(5):379-85.
-
1998: Frasci G; Comella P; Panza N; De Cataldis G; Del Gaizo F; Pozzo C; Gravina A; Ruffolo P; Cioffi R; Marcatili P; Della Vittoria M; Monfardini S; Comella G
Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-Italia.
European journal of cancer (Oxford, England : 1990) 1998;34(11):1710-4.
-
1998: Frasci G; Comella P; D'Aiuto G; Budillon A; Barbarulo D; Thomas R; Capasso I; Casaretti R; Daponte A; Caponigro F; Gravina A; Maiorino L; Caratení G; Gentile A; Comella G
Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study.
Breast cancer research and treatment 1998;49(1):13-26.
-
1998: Bajetta E; Di Bartolomeo M; Carnaghi C; Buzzoni R; Mariani L; Gebbia V; Comella G; Pinotti G; Ianniello G; Schieppati G; Bochicchio A M; Maiorino L
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
British journal of cancer 1998;77(7):1149-54.
-
1997: Frasci G; Panza N; Comella P; Nicolella G P; Natale M; Pacilio C; Gravina A; Caputi V; Botti G; Comella G
Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(10):1045-8.
-
1997: Comella G; Frasci G; Scoppa G; Guida C; Gravina A; Fiore F; Casaretti R; Daponte A; Ruffolo P; Comella P
Weekly paclitaxel/cisplatin with concurrent radiotherapy in patients with locally advanced non-small cell lung cancer: a phase I study.
Seminars in oncology 1997;24(4 Suppl 12):S12-113-S12-116.
-
1997: Comella P; Daponte A; Casaretti R; Ionna F; Fiore F; Presutti F; Frasci G; Caponigro F; Gravina A; Parziale A P; Mozzillo N; Comella G
Fotemustine and dacarbazine plus recombinant interferon alpha 2a in thetreatment of advanced melanoma.
European journal of cancer (Oxford, England : 1990) 1997;33(8):1326-9.
-
1997: Bajetta E; Zilembo N; Barni S; Noberasco C; Martinetti A; Ferrari L; Schieppati G; Buzzoni R; Jirillo A; Amichetti M; D'Aprile M; Comella G; Bichisao E; Bolelli G F; Attili A; Bombardieri E
A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(7):649-54.
-
1997: Frasci G; Comella P; Scoppa G; Guida C; Gravina A; Fiore F; Casaretti R; Daponte A; Parziale A; Comella G
Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1409-17.
-
1997: Frasci G; Comella P; Parziale A; Casaretti R; Daponte A; Gravina A; De Rosa L; Gallipoli A; Comella G
Cisplatin-paclitaxel weekly schedule in advanced solid tumors: a phase I study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(3):291-3.
-
1997: Labianca R; Cascinu S; Frontini L; Barni S; Fiorentini G; Comella G; Zaniboni A; Gottardi O; Arnoldi E; Oliani C; Duro M; Pavanato G; Martignoni G; Raina A; Piazza E; Dallavalle G; Valsecchi R; Pancera G; Luporini G
High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(2):169-74.
-
1996: Comella P; Frasci G; De Cataldis G; Panza N; Cioffi R; Curcio C; Belli M; Bianco A; Ianniello G; Maiorino L; Della Vittoria M; Perchard J; Comella G
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
British journal of cancer 1996;74(11):1805-11.
-
1996: Baldini E; Tibaldi C; Pfanner E; Ricci S; Falcone A; Ceribelli A; Sarcina R; Comella G; Stampino C G; Conte P F
Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer.
American journal of clinical oncology 1996;19(6):592-4.
-
1996: Bajetta E; Di Bartolomeo M; Somma L; Moreschi M; Comella G; Turci D; Gebbia V; Scanni A; Bordogna G; Stampino C G
Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma.
Cancer 1996;78(10):2087-93.
-
1996: Comella P; Palmieri G; Lorusso V; Catalano G; Nicollela D; Ianniello G P; Casaretti R; Montella M; Frasci G; Perna M; Comella G
Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies.
European journal of cancer (Oxford, England : 1990) 1996;32A(10):1719-26.
-
1996: Comella P; Frasci G; Panza N; De Cataldis G; Cioffi R; Curcio C; Nicolella D; Micillo E; Ianniello G P; Biondi E; Perchard J; Comella G
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trial.
Lung cancer (Amsterdam, Netherlands) 1996;15(1):103-14.
-
1996: Comella P; Palmieri G; Beneduce G; Casaretti R; Daponte A; Gravina A; Frasci G; Biondi E; Comella G
Significance of methotrexate serum level achieved in patients with gastrointestinal malignancies treated with sequential methotrexate, L-folinic acid and 5-fluorouracil.
Oncology 1996;53(3):198-203.
-
1996: Frasci G; Conforti S; Zullo F; Mastrantonio P; Comella G; Comella P; Persico G; Iaffaioli R V
A risk model for ovarian carcinoma patients using CA 125: time to normalization renders second-look laparotomy redundant.
Cancer 1996;77(6):1122-30.
-
1995: Frasci G; Comella G; Comella P; Salzano F; Cremone L; Della Volpe N; Imbriani A; Persico G
Mitoxantrone plus vinorelbine with granulocyte-colony stimulating factor (G-CSF) support in advanced breast cancer patients. A dose and schedule finding study.
Breast cancer research and treatment 1995;35(2):147-56.
-
1995: Frasci G; Comella G; Comella P; Conforti S; Mastrantonio P; Zullo F; Persico G
Carboplatin (CBDCA)-hexamethylmelamine (HMM)-oral etoposide (VP-16) first-line treatment of ovarian cancer patients with bulky disease: a phase II study.
Gynecologic oncology 1995;58(1):68-73.
-
1995: Comella P; Biglietto M; Della Vittoria Scarpati M; Stampino C G; Pandolfi A; Palmieri G; Carteni G; Catalano G; Comella G
Dose-finding study of 5'-deoxy-5-fluorouridine in combination with fixed doses of cisplatin and L-folinic acid for the treatment of advanced or recurrent squamous cell carcinoma of the head and neck.
Oncology 1995;52(4):326-30.
-
1995: Di Leo A; Bajetta E; Buzzoni R; Bochicchio A M; Nolè F; Biganzoli L; D'Aprile M; Veltri E; Comella G; Aitini E
Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer. A study by the Italian Trials in Medical Oncology Group.
American journal of clinical oncology 1995;18(3):239-44.
-
1995: Frasci G; Perillo G; Comella G; Comella P; Polverino M; Menzella G; Persico G
Phase I/II study of carboplatin and oral etoposide with granulocyte-colony stimulating factor in advanced nonsmall cell lung cancer.
Cancer 1995;75(7):1578-85.
-
1994: Comella P; Scoppa G; Daponte A; Musetta G; Anania C; Maiorino A; Curcio C; Casaretti R; Comella G
Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
Cancer 1994;74(7):1874-81.
-
1994: Gridelli C; D'Aprile M; Curcio C; Brancaccio L; Palmeri S; Comella G; Veltri E; Ferrante G; Gentile M; Rossi A
Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI).
Lung cancer (Amsterdam, Netherlands) 1994;11(1-2):83-91.
-
1994: Gridelli C; Ianniello G P; Maiorino A; Curcio C; D'Aprile M; Brancaccio L; Palmeri S; Gentile M; Comella G; Pedicini T
Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer.
American journal of clinical oncology 1994;17(2):160-2.
-
1994: Mustacchi G; Pavesi L; Milani S; Iaffaioli V; Caraco A; Comella G; Contu A; Farris A; Attado-Parinello G; Narcisi M
High-dose folinic acid (FA) and fluorouracil (FU) plus or minus thymostimulin (TS) for treatment of metastatic colorectal cancer: results of a randomized multicenter clinical trial.
Anticancer research 1994;14(2B):617-9.
-
1994: Comella P; Casaretti R; Daponte A; Bartoli G C; Parziale A P; Palmieri G; Comella G
Combination of vinorelbine, cisplatin, and etoposide in advanced non-small cell lung carcinoma: a pilot study.
Journal of chemotherapy (Florence, Italy) 1994;6(1):67-71.
-
1994: Frasci G; Iaffaioli R V; Comella G; Comella P; Salzano F; Galizia G; Imbriani A; Persico G
Intraperitoneal adjuvant immunochemotherapy in operable gastric cancer with serosal involvement.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1994;6(6):364-70.
-
1993: Castello G; Comella P; Manzo T; Napolitano M; Parziale A P; Galati M G; Daponte A; Casaretti R; Celentano E; Comella G
Immunological and clinical effects of intramuscular rIFN alpha-2a and low dose subcutaneous rIL-2 in patients with advanced malignant melanoma.
Melanoma research 1993;3(1):43-9.
-
1993: Bajetta E; Colleoni M; Rosso R; Sobrero A; Amadori D; Comella G; Marangolo M; Scanni A; Lorusso V; Calabresi F
Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(12):1658-63.
-
1993: Labianca R; Pancera G; Barni S; Cascinu S; Comella G; Foa P; Martignoni G; Zaniboni A; Giaccon G; Luporini G
Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer).
Advances in experimental medicine and biology 1993;339():233-7.
-
1991: Comella G; Casaretti R; Comella P; Daponte A; Parziale A; Iervolino V; Santillo G; Zarrilli D
Treatment of advanced colorectal cancer with mitoxantrone, high dose folinic acid and fluorouracil.
Tumori 1991;77(5):445-6.
-
1991: Labianca R; Pancera G; Aitini E; Barni S; Beretta A; Beretta G D; Cesana B; Comella G; Cozzaglio L; Cristoni M
Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(9):673-9.
-
1991: Comella G; Daponte A; Comella P; Casaretti R; Iervolino V; Santillo G; Zarrilli D
Combination chemotherapy with vinblastine, BCNU and cisplatin in advanced malignant melanoma.
Tumori 1991;77(3):216-8.
-
1990: Claudio F; Cacace F; Comella G; Coucourde F; Claudio L; Bevilacqua A M; Toma S
Intraarterial chemotherapy through carotid transposition in advanced head and neck cancer.
Cancer 1990;65(7):1465-71.
-
1990: Merlano M; Bacigalupo A; Benasso M; Grimaldi A; Toma S; Benedetti G; Comella G; Cacace F; Rosso R
5-Fluorouracil and high-dose folinic acid as second-line chemotherapy in head and neck cancer.
American journal of clinical oncology 1990;13(1):1-3.
-
1986: Comella G; Mastro A A; Comella P; Castello G; De Simone G; Cerra R; Zarrilli D
[5-year results of a chemo-immunotherapeutic treatment in stage-I and -II malignant melanoma]
Minerva medica 1986;77(13):507-10.
-
1985: Comella G; Scoppa G; De Marco M; Ianniello G P; Melillo G; Coucourde F; Zarrilli D
Radiotherapy and combination chemotherapy with carmustine, vincristine, and procarbazine (BVP) in primary brain tumors.
Journal of neuro-oncology 1985;3(1):13-7.
-
1983: Comella P; De Rosa V; Frezza P; Bevilacqua A; Scoppa G; Abate G; Comella G; Pergola M; Zarrilli D
Influence on response to therapy and overall survival of mediastinal involvement by Hodgkin's disease.
Tumori 1983;69(1):53-8.
-
1982: Comella P; Scoppa G; Abate G; Comella G; Apice G; Castello G; Pergola M; Giordano G G; Coucourde F; Zarrilli D
Combination chemotherapy (CVP or CHOP)- radiotherapy approach in early stage non-Hodgkins's lymphomas.
Tumori 1982;68(2):137-42.
-
1980: Comella P; Abate G; Comella G; Bruni G S; Zarrilli D; Pergola M
Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) for non-Hodgkin's lymphomas with unfavorable histology: preliminary results.
Tumori 1980;66(6):749-56.
Sign-in to see more
